Anti-tubercular Activity of Ruthenium (II) Complexes with Polypyridines

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 2, 2009, Pages 457-463

  Hadda, Taibi Ben ^a   Akkurt, Mehmet ^b   Baba, Mohamed Filali ^c   Daoudi, Maria ^c   Bennani, Brahim ^c   Kerbal, Abdelali ^c   Chohan, Zahid H ^d  

^a FACULTÉ DES SCIENCES   (Morocco)

^b ERCIYES UNIVERSITY   (Turkey)

^c Sidi Mohamed Ben Abdellah University   (Morocco)

^d BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

Author keywords

Anti tubercular activity; Polypyridines; Ruthenium (II) complexes

Indexed keywords

ACETONITRILE DERIVATIVE; POLYPYRIDINE DERIVATIVE; POLYPYRIDYLRUTHENIUM COMPLEX; PYRIDINE DERIVATIVE; RUTHENIUM COMPLEX; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; 2,2' BIPYRIDINE; DRUG DERIVATIVE; LIGAND; ORGANOMETALLIC COMPOUND; RUTHENIUM;

ANTIBACTERIAL ACTIVITY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REPRODUCIBILITY; CHEMISTRY; DRUG EFFECT; ELECTROCHEMISTRY; METABOLISM;

MYCOBACTERIUM TUBERCULOSIS;

2,2'-DIPYRIDYL; ANTITUBERCULAR AGENTS; ELECTROCHEMISTRY; LIGANDS; MYCOBACTERIUM TUBERCULOSIS; ORGANOMETALLIC COMPOUNDS; RUTHENIUM;

EID: 68049113520     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360802188628     Document Type: Article

References (32)

1. Heym B, Cole ST. Multidrug resistance in Mycobacterium tuberculosis. Int J Antimicrob Agents 1997;8: 61-70.
2. Basso LA, Blanchard JS. Resistance to antitubercular drugs. Adv Exp Med Biol 1998;456: 115-144.
3. Telenti A, Iseman M. Drug-resistant tuberculosis: What do we do now? Drugs 2000;59: 171-179.
4. Loiez-Durocher C, Vachee A, Lemaitre N. Drug resistance in Mycobacterium tubercolosis: Diagnostic methods. Ann Biol Clin 2000;58: 291-297.
5. Duncan K. Prospects for new anti-tuberculosis drugs. J Pharm Pharmacol 1997;49: 21-23.
6. Duncan K. Tuberculosis: Annual update. Expert Opin Ther Pat 1997;7: 129-137.
7. Grassi C. New drugs for tuberculosis. Expert Opin Invest Drugs 1997;6: 1211-1226.
8. Barry CE. New horizons in the treatment of tuberculosis. Biochem Pharmacol 1997;54: 1165-1172.
9. Duncan K. Tuberculosis. Expert Opin Ther Pat 1998;8: 137-142.
10. Snell NJC. The treatment of tuberculosis: Current status and future prospects. Expert Opin Invest Drugs 1998;7: 545-552.
11. Crick DC, Brennan PJ. Antituberculosis drug research. Curr Opin Anti-Infect Invest Drugs 2000;2: 154-163.
12. Andreani A, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M. Synthesis and antitubercular activity of imidazo[2,1-b ]thiazoles. Eur J Med Chem 2001;36: 743-746.
13. Bottari B, Maccari R, Monforte F, Ottanaa R, Rotondo E, Vigorita MG. Antimycobacterial in vitro activity of cobalt (II) isonicotinoylhydrazone complexes. Part 10. Bioorg Med Chem Lett 2000;10: 657.
14. Kumar A, Kumar D. Synthesis and antimicrobial activity of metal complexes from 2-(10/20-hydroxynaphthyl)benzoxazoles. ARKIVOC 2007;(XIV): 117-125.
15. Bottari B, Maccari R, Monforte F, Ottana R, Vigorita MG, Bruno G, Nicolo F, Rotondo A, Rotondo E. Nickel (II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI. Bioorg Med Chem 2001;9: 2203-2211.
16. Messori L, Orioli P, VulloD, Alessio E, Iengo E.Aspectroscopic study of the reaction of NAMI, a novel ruthenium (III) antineoplastic complex, with bovine serumalbumin. Eur J Biochem 2000;267: 1206-1213.
17. Dwyer FP, Reid IK, Shulman A, Laycock GM, Dixon S. Biological actions of 1,10-phenanthroline and 2,20-bipyridine hydrochlorides, quaternary salts and metal chelates and related compounds. 1. Bacteriostatic action on selected gram-positive, Gram-negative and acid-fast bacteria.Austral J Exp BioMed Sci 1969;47: 203-218.
18. Sam N, Elkadiri S, Le Bozec H, Toupet L, Daoudi M, Bitit N, BenHaddaT, Dixneuf PH.Novel trichloroindolizine derivatives via intramolecular acylation of a bis(chloroacyl)bipyridine. J Chem Soc Perkin Trans 2002;1(14): 1688-1692
19. (b) Ben HaddaT,SamN,LeBozecH,DixneufPH.Carbonyl andchloro complexes of ruthenium (II) containing 3,30-diester-2,20- bipyridyl ligands, Inorg Chem Comm, 1999, 2, 460-462.
20. (c) Ben Hadda T, Zidane I, Moya SA, LeBozec H. Soluble containing ruthenium carbonyl complexes new sterically hindered bipyridine ligands. Polyhedron 1996;15(9): 15711573.
21. Collins L, Franzblau SG.Microplate Alamar blue assay versus BACTEC 460 system for high- throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997;41: 1004-1009.
22. Hurst JK.Water oxidation catalyzed by dimeric m-oxo bridged ruthenium diimine complexes. Coord Chem Rev 2005;249: 313-328
23. Chatterjee D, Mitra A, Shepherd RE. Oxo-transfer catalysis from t-BuOOH with C-H bond insertion using tridentate Schiff-base-chelate complexes of ruthenium(III). Inorg Chim Acta, 357 (2004), 980-990.
24. Chanda N, Mondal, B, Puranik, VG, Lahiri GK. Ruthenium monoterpyridine complexes incorporating a,a0- diimine based ancillary functions. Synthesis, crystal structure, spectroelectrochemical properties and catalytic aspect. Polyhedron 2002;21: 2033-2043.
25. Chatterjee D, Mitra A, Mukherjee S. Oxidation of benzene with tert-butylhydroperoxide catalyzed by a novel [RuIII(amp)(bipy)(H2O)]p complex: First report of homogeneously catalyzed oxo-transfer reaction in benzene oxidation. J Mol Cata A Chem 2001;165: 295-298.
26. Chatterjee D, Mitra A. Oxidation of organic substrates catalyzed by a novel mixed-ligand [RuIII(app)(pic)(H2O)]p complex Inorg Chem Comm, 2000;3: 640-644.
27. Frézard F, Demicheli C, Ferreira C, Costa MAP. Glutathioneinduced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate. Antimicrob Agents Chemother 2001;: 913-916.
28. Chatterjee D, Mitra A. Ruthenium polyaminocarboxylate complexes. Platinum Metals Rev 2006;50(1): 2-12.
29. Chohan ZH, Arif M, Akhtar MA, Supuran CT. Metal-based antibacterial and antifungal agents: Synthesis, characterization, and in vitro biological evaluation of Co(II), Cu(II), Ni(II), and Zn(II) complexes with amino acid-derived compounds. Bioinorg Chem Appl 2006;1-13.
30. Chohan ZH, Shad HA. Structural elucidation and biological significance of 2-hydroxy-1-naphthaldehyde derived sulfonamides and their first row d-transition metal chelates. J Enz Inhib Med Chem 2008; (in press).
31. Chohan ZH, Supuranm CT, Scozzafava A. Metal binding and antibacterial activity of ciprofloxacin complexes. J Enz Inhib Med Chem 2005;20(3): 303-307.
32. Chohan ZH, Supuranm CT. Metalloantibiotics: Synthesis, characterization and in-vitro antibacterial studies on cobalt (II), copper (II), nickel (II) and zinc (II) complexes with cloxacillin. J Enz Inhib Med Chem 2006;21(4): 441-448.